论文部分内容阅读
[目的]探讨食管癌、贲门癌合并糖尿病患者的围手术期治疗。[方法]回顾性分析1999年6月至2009年6月中国医学科学院肿瘤医院连续手术治疗的288例食管癌、贲门癌合并糖尿病病例的临床资料,总结围手术期治疗的经验和教训。糖尿病的诊断按照WHO1999年推荐的分型和诊断标准。[结果]全组无酮症酸中毒或高渗性昏迷发生。胸内吻合口瘘的发生率为1.7%(4/235),颈部吻合口瘘的发生率为13.2%(7/53)。切口愈合不良的发生率为6.6%。死亡率为1.7%。[结论]食管癌、贲门癌合并糖尿病患者围手术期严格监测和控制血糖,手术治疗是比较安全的。
[Objective] To investigate the perioperative treatment of patients with esophageal cancer and cardia cancer with diabetes mellitus. [Methods] The clinical data of 288 cases of esophageal and cardia cancer complicated with diabetes mellitus treated by continuous operation from June 1999 to June 2009 in Cancer Hospital of China Academy of Medical Sciences were retrospectively analyzed. The experiences and lessons of perioperative treatment were summarized. The diagnosis of diabetes in accordance with WHO1999 classification and diagnostic criteria. [Results] The whole group without ketoacidosis or hyperosmolar coma occurred. The incidence of intrathoracostomy fistula was 1.7% (4/235), and the incidence of anastomotic fistula was 13.2% (7/53). The incidence of incisional healing was 6.6%. The death rate was 1.7%. [Conclusion] Perioperative monitoring and control of blood glucose in patients with esophageal cancer and cardia cancer with diabetes mellitus are feasible. Surgical treatment is safe.